Health Risks of Microplastics Highlighted at Recent Medical Conferences
Nivolumab With Ipilimumab Approved by FDA for Use in Hepatocellular Carcinoma
Eteplirsen Treatment Linked to Slower Cardiac Decline in DMD
COVID-19 Linked to Increased Kidney Risks in Children